These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23289177)

  • 1. [Practical information about Qutenza patch: capsaicin "reloaded"].
    Kiss G
    Ideggyogy Sz; 2012 Nov; 65(11-12):417-9. PubMed ID: 23289177
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.
    Martini CH; Yassen A; Krebs-Brown A; Passier P; Stoker M; Olofsen E; Dahan A
    Eur J Pain; 2013 Nov; 17(10):1491-501. PubMed ID: 23650124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qutenza patch--our early experience.
    Weekes G; O'Brien J; Murphy K; Keavney J; Pollard V
    Ir Med J; 2013 Mar; 106(3):89-90. PubMed ID: 23951983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
    Jones VM; Moore KA; Peterson DM
    J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience.
    Filipczak-Bryniarska I; Krzyzewski RM; Kucharz J; Michalowska-Kaczmarczyk A; Kleja J; Woron J; Strzepek K; Kazior L; Wordliczek J; Grodzicki T; Krzemieniecki K
    Med Oncol; 2017 Aug; 34(9):162. PubMed ID: 28819738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Pain; 2013 Sep; 154(9):1632-1639. PubMed ID: 23707278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
    Blair HA
    Drugs; 2018 Sep; 78(14):1489-1500. PubMed ID: 30251173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia.
    Wallace M; Pappagallo M
    Expert Rev Neurother; 2011 Jan; 11(1):15-27. PubMed ID: 21158551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Irving GA; Backonja MM; Dunteman E; Blonsky ER; Vanhove GF; Lu SP; Tobias J;
    Pain Med; 2011 Jan; 12(1):99-109. PubMed ID: 21087403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.
    Gálvez R; Navez ML; Moyle G; Maihöfner C; Stoker M; Ernault E; Nurmikko TJ; Attal N
    Clin J Pain; 2017 Oct; 33(10):921-931. PubMed ID: 28872473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain.
    Noto C; Pappagallo M; Szallasi A
    Curr Opin Investig Drugs; 2009 Jul; 10(7):702-10. PubMed ID: 19579176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
    Aitken E; McColl G; Kingsmore D
    Pain Med; 2017 Feb; 18(2):330-340. PubMed ID: 28204726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
    Hansson P; Jensen TS; Kvarstein G; Strömberg M
    Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical capsaicin reduces ultraviolet radiation-induced suppression of Mantoux reactions in humans.
    Howes RA; Halliday GM; Barnetson RS; Friedmann AC; Damian DL
    J Dermatol Sci; 2006 Nov; 44(2):113-5. PubMed ID: 16973333
    [No Abstract]   [Full Text] [Related]  

  • 15. Capsaicin patch (Qutenza) for postherpetic neuralgia.
    Med Lett Drugs Ther; 2011 May; 53(1365):42-3. PubMed ID: 21617594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series.
    Gaul C; Resch S
    Cephalalgia; 2015 May; 35(6):545-50. PubMed ID: 25217483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chillies: out of the frying pan and into the clinic?
    Lancet; 2007 Oct; 370(9595):1284. PubMed ID: 17933627
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral Neuropathy Associated with Hypereosinophilic Syndrome: A Clinical Therapeutic Success with Capsaicin 8% Patch.
    Ruivo EFM; Gestosa SVS; Mulenas NME; Lares AMG
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):155-158. PubMed ID: 32223588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction to topical capsaicin in spinal cord injury patients with and without central pain.
    Finnerup NB; Pedersen LH; Terkelsen AJ; Johannesen IL; Jensen TS
    Exp Neurol; 2007 May; 205(1):190-200. PubMed ID: 17346705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin 8% dermal patch in clinical practice: an expert opinion.
    Bonezzi C; Costantini A; Cruccu G; Fornasari DMM; Guardamagna V; Palmieri V; Polati E; Zini P; Dickenson AH
    Expert Opin Pharmacother; 2020 Aug; 21(11):1377-1387. PubMed ID: 32511032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.